
Carmel Carmel Pharma is the manufacturer of the PhaSeal System, today’s only clinically proven closed-system drug transfer device for the safe handling of hazardous drugs. Supported by more than 15 years of experience focused solely on the development of PhaSeal, Carmel Pharma offers the highest level of trust, quality and confidence.
In 2012, after a successful investment period from 2002 to 2012, Industrifonden exited its investment in Carmel Pharma as the company was acquired by Becton Dickinson.